Weight Loss Drugs Are Quietly Transforming the Economy in Unexpected Ways

By

Diccon Hyatt

Diccon Hyatt

Full Bio Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic currents would have on individuals' finances and the market. He has a Bachelor's degree in English from the University of Delaware.

Learn about our editorial policies

Published May 22, 2026

11:43 AM EDT

A commercial for GLP-1 drugs during the Super Bowl LX broadcast on television screens at a bar

A commercial for GLP-1 drugs during the Super Bowl LX broadcast on television screens at a bar in Los Angeles, California, US, on Sunday, Feb. 8, 2026. Jill Connelly / Bloomberg via Getty Images

  • Increasingly popular weight loss drugs are affecting the finances of people who take them in large ways and small.
  • People who take GLP-1s significantly cut back on eating out and food delivery, and need to buy new clothes, according to surveys.
  • The changes in lifestyle could result in new or changed expenses on top of the cost of the drugs, which can be up to $1,000 a month.

Get personalized, AI-powered answers built on 27+ years of trusted expertise.

Weight-loss drugs are reshaping the spending habits of those who take them, influencing the broader economy in subtle yet noticeable ways.

New surveys shed light on how popular GLP-1 medications such as Ozempic and Monjauro change how people eat, drink, and shop, even after they stop taking them. A survey by Deutsche Bank found people taking the drugs went to restaurants and ordered out half as often as they did before, while spending slightly more at each visit.1

A separate analysis by market research firm Coresight found 72% of GLP-1 users had dropped at least one clothing size, suggesting an increased need to buy clothes. They are also contributing to the estimated $47 billion in apparel customers send back to online retailers each year because it doesn't fit.

What This Means For the Economy

The rise of GLP-1 medications could affect the economy by changing consumer preferences and expenditures, for instance, shifting spending away from restaurants and toward groceries.

"While we're all salivating at the prospect of where AI can go in the years ahead, perhaps the bigger leap in the near term is the technological miracle that is stopping us salivating at all," Jim Reid, global head of macro and thematic strategy at Deutsche Bank, wrote in a commentary. "Maybe GLP-1 is the real short-term general-purpose technology for a wider range of consumers, especially in the U.S."

The new data illuminate the less obvious financial effects of the medications, which nearly 12% of U.S. adults have used at some point, according to a poll last August by Rand.2 They could be even more popular now that the drugs are being released in the form of pills rather than injections.

These changes are minor compared to the cost of medications themselves, which can reach up to $1,000 a month, depending on the brand and whether they are covered by insurance.3

The drugs do save patients money in the long run by preventing costly chronic illnesses such as diabetes. However, the benefit does not outweigh the cost, according to an analysis last year by researchers at the University of Chicago. They found that covering GLP-1s for weight loss through Medicaid would cost about $66 billion but only save $18 billion by preventing other illnesses.4

Economists and other researchers have been studying how the drugs could impact the economy far beyond healthcare. For example, they could save airlines as much as $580 million a year in fuel costs by making passengers lighter, according to an analysis by financial firm Jeffries, reported earlier this year.5

RELATED EDUCATION

[Understanding Consumer Discretionary: Key Products and Economic Insights

Consumer Discretionary: Companies that sell non-essential consumer goods and services.](https://www.investopedia.com/terms/c/consumer-discretionary.asp) [Hard and Soft Goods in Retail

Smiling young pregnant woman shopping for home necessities in shop](https://www.investopedia.com/ask/answers/070715/what-do-hard-and-soft-goods-retail-sector-refer.asp)

Deutsche Bank’s survey of 550 people showed GLP-1 users changed what they bought, in addition to where they ate, buying less chocolate, candy, ice cream, and salty snacks and more fruits, vegetables, nuts, and protein shakes,for example.

The changes to dining out habits mostly stuck even after people quit the medication, according to the poll.

Do you have a news tip for Investopedia reporters? Please email us at

tips@investopedia.com

Get personalized, AI-powered answers built on 27+ years of trusted expertise.

Article Sources

Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.

  1. Deutsche Bank. "Sizing Up GLP-1 Impacts: Survey Shows Durable Shift in Pharma, Diets, and Dining."
  2. Rand. "New Weight Loss Drugs."
  3. Penn LDI. "Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic."
  4. The University of Chicago Medicine. “Are GLP-1 drugs worth their current cost?.”
  5. New York Times. "Weight-Loss Drugs Could Save U.S. Airlines $580 Million Per Year."

Read more

Partner Links